Power quality issues of heavy industry, especially iron and steel plants, require special solutions. High levels of harmonic currents, unbalanced operation and light flicker arising from rapid fluctuations of active and reactive power demands are common problems in these plants. Almost all of these plants in Turkey are equipped with modern Static Var Compensator (SVC) Systems. In this thesis, alternative control strategies and flicker compensation system topologies are investigated and evaluated based on real-time field data and compared with the existing SVC systems. It is found out that the currently installed SVCs are not fully capable of solving the power quality issues of EAFs. This thesis is dedicated to detailed analysis, design, control, and simulation of TCR based SVC using instantaneous power theory, Three Phase Bridge Connected STATCOM and Delta Connected STATCOM. These 3 different types of compensators are modelled based on the similar installed capacities and their contribution to voltage quality and reactive power compensation are compared.

La différenciation des lymphocytes T dans le thymus est strictement contrôlée par le réarrangement des gènes codants pour les chaînes du TCR et leur expression en surface dans le cadre du pré-TCR ou du TCR. Les souris incapables d'assembler un pré-TCR présentent un blocage précoce du développement des thymocytes. Nous avons montré que l'irradiation de souris CD3ε-/-, qui sont déficientes en pré-TCR, restaure la différenciation des thymocytes par des voies différentes selon que p53 soit présente ou non. En réponse à l'irradiation, il existe une dissociation temporelle de l'activation des voies de signalisations contrôlant plusieurs événements co-régulés durant le développement des thymocytes. Ces voies sont cependant toutes deux centralisées au niveau de LAT. L'irradiation induit donc des voies de signalisations mimant les effets de l'activation du pré-TCR.<br />La différenciation radio-induite des thymocytes immatures s'accompagne du réarrangement de novo des gènes TCRA. L'étude des jonctions signal (JS) formées lors du réarrangement des gènes TCRA ne montre pas de différences de structure entre les JS de souris sauvages ou les JS formées suite à l'irradiation. Le réarrangement TCRA radio-induit est donc probablement l'œuvre de la machinerie de recombinaison traditionnelle. Contrairement au modèles actuels de recombinaison V(D)J les JS de souris sauvages analysées présentent des modifications, quels que soient les gènes réarrangés. Nous avons pu montrer une influence de plusieurs protéines impliquées dans la réparation de l'ADN et le maintient de la stabilité du génome sur la structure des JS. Nous proposons que ces modifications ne sont pas le résultat d'un processus de recombinaison aberrant mais constituent une propriété intrinsèque de la recombinaison. <br />Nos travaux permettent donc une meilleure compréhension des mécanismes moléculaires de la recombinaison V(D)J.

Deux types de problématiques différentes peuvent motiver l'approche structurale d'une macromolécule. Soit la fonction de cette macromolécule est inconnue et l'on détermine sa structure afin de mieux connaître sa fonction ; cette démarche était l'un des défis du développement de la génomique structurale. Soit la fonction est connue et la structure va permettre de comprendre comment cette molécule remplit son rôle biologique.<br />Durant ma thèse, j'ai eu l'occasion de pouvoir aborder deux projets structuraux très différents, qui correspondent à ces deux approches de biologie structurale. C'est pourquoi mon manuscrit décrit ces deux projets dont la démarche scientifique est différente et complémentaire pour ma formation en biologie structurale. <br />Dans un premier temps, je décrirai les résultats obtenus sur le projet PAB0955, débuté en stage de DEA et poursuivi pendant les deux premières années de ma thèse. Ce projet avait pour objectif de déterminer la fonction de la protéine d'après sa structure. La protéine PAB0955 est de fonction biologique inconnue, elle hydrolyse le GTP et elle n'a pas de proche homologue dont la structure est connue. La démarche scientifique de ce projet a été de déterminer la structure de cette protéine, puis d'analyser sa structure en la comparant de manière systématique à l'ensemble des protéines ATPases et GTPases. Notre étude a été conduite dans l'objectif extraire un maximum d'information fonctionnelle à partir des données structurales.<br />Dans une deuxième partie, je décrirai notre étude sur des protéines du système immunitaire humain débuté en troisième année de thèse. Nous nous sommes intéressés à des molécules impliquées dans la reconnaissance d'antigène : le récepteur du lymphocyte T (TCR) et la molécule du complexe majeur d'histocompatibilité (CMH). L'objectif de ce projet est de comprendre comment un complexe antigène-CMH sélectionne un répertoire de lymphocyte T spécifique. L'objectif étant de déterminer le lien entre les caractéristiques structurales d'un complexe antigène-CMH et la diversité et la fréquence des lymphocytes T activés par ce complexe. En résumé corréler les observations structurales avec les données immunologiques dont nous disposons. En déterminant les bases structurales du caractère antigénique d'un peptide présenté par une molécule CMH nous pourrons, à plus long terme, produire des peptides efficaces dans le cadre d'une vaccination

High-throughput technologies in biological sciences have led to an exponential growth in the amount of data generated over the past several years. This data explosion is forcing scientists to search for innovative computational designs to reduce the time-scale of biological system simulations, and enable rapid study of larger and more complex biological systems. In the field of immunobiology, one such simulation is known as DNA recombination. It is a critical process for investigating the correlation between disease and immune system responses, and discovering the immunological changes that occur during aging through T-cell repertoire analysis. In this project we design and develop a massively parallel method tailored for Graphics Processing Unit (GPU) processors by identifying novel ways of restructuring the flow of the repertoire analysis. The DNA recombination process is the central mechanism for generating diversity among antigen receptors such as T-cell receptors (TCRs). This diversity is crucial for the development of the adaptive immune system. However, modeling of all the α β TCR sequences is encumbered by the enormity of the potential repertoire, which has been predicted to exceed 10¹⁵ sequences. Prior modeling efforts have, therefore, been limited to extrapolations based on the analysis of minor subsets of the overall TCR β repertoire. In this study, we map the recombination process completely onto the GPU hardware architecture using the CUDA programming environment to circumvent prior limitations. For the first time, a model of the mouse TCRβ is presented to an extent which enabled the evaluation of the Convergent Recombination Hypothesis (CRH) comprehensively at a peta-scale level on a single GPU. Understanding the recombination process will allow scientists to better determine the likelihood of transplant rejections, immune system responses to foreign antigens and cancers, and plan treatments based on the genetic makeup of a given patient.

Themis est une protéine de signalisation des récepteurs des lymphocytes T (TCR) essentielle pour la sélection positive des cellules T. La fonction moléculaire de Themis a été controversée mais de récentes études suggèrent qu'il est un régulateur positif des voies de signalisation des TCR. Nous avons montré dans une étude préliminaire que Themis interagit avec des déubiquitinases et qu'il est ubiquitiné dans les thymocytes. L'objectif de ma thèse était de caractériser les mécanismes moléculaires qui régulent l'ubiquitination de Themis et de déterminer si ces processus affectent la fonction de Themis durant le développement des lymphocytes T. Nous avons montré que si l'expression des ARNm codant pour Themis diminue dans les stades précoces de la sélection positive, son expression protéique est parallèlement augmentée, suggérant une stabilisation de Themis par des modifications post-traductionnelles durant cette étape. Nous avons montré que la déubiquitinase USP9X déubiquitine Themis pour stabiliser son expression durant la stimulation des TCR. L'ensemble de nos résultats proposent qu'USP9X soit activé durant la stimulation des TCR grâce à son recrutement dans les complexes proximaux des TCR par l'intermédiaire de l'adaptateur Grb2 et Themis, entrainant la stabilisation de l'expression de Themis. Nous pensons que ce mécanisme est important pour maintenir l'expression de Themis durant la sélection positive afin de favoriser l'induction d'un signal des TCR soutenu, requis pour l'efficacité de ce processus. / The protein Themis is a new actor of the T cell receptor (TCR) signaling essential for the positive selection of T cells. The molecular function of Themis has been controversial but recent findings suggest that it acts as positive regulator of TCR signaling. We demonstrated in an initial research that Themis interacts with deubiquitylases and is covalently associated to ubiquitin chains in thymocytes. The aim of my PhD project was to characterize the molecular process that regulates the ubiquitination of Themis and to investigate how these post-translational modifications affect Themis function during T cell development. We demonstrated that Themis mRNA expression is progressively decreased after positive selection whereas Themis protein expression is enhanced at the early stages of positive selection, suggesting that Themis is stabilized by post-translational modifications during positive selection. We demonstrated that USP9X allows the deubiquitination of Themis and its stabilization following TCR engagement. Ours results suggest that USP9X is activated during TCR engagement following its recruitment to proximal signaling complexes through Grb2 and Themis, leading to the deubiquitination and stabilization of Themis expression. We believe that this mechanism is important to sustain Themis expression during positive selection and to promote durable TCR signals required for the efficiency of this process.

The strength of peptide:MHC interactions with the T cell receptor (TCR) is correlated with the time to first cell division, the relative scale of the effector cell response, and the graded expression of activation-induced proteins. The TCR proximal tyrosine kinase ITK simultaneously influences many biochemically separate signaling cascades. T cells lacking ITK exhibit selective impairments in effector T cell responses after activation, but under the strongest signaling conditions ITK activity is dispensable. To gain insight into whether TCR signal strength and ITK activity tune observed graded gene expression through unequal activation of disparate signaling pathways, I examined NFAT, NF-κB and MAP kinase pathways during early activation of individual naïve OT-I CD8+ T cells using peptide-loaded antigen presenting cells. Utilizing both measurement of transcription factor translocation in single T cell nuclei and conventional phospho-flow cytometry, I observed digital activation of Erk-MAPK and NFAT1 at all peptide doses and avidities. However, NF-κB activation showed a graded response to variation in TCR signal strength and was more sensitive to treatment with an ITK inhibitor. Inhibitor-treated cells showed poor induction of AP-1 factors Fos and Fosb, NF-κB response gene transcripts, and survival factor Il2 transcripts. ATAC-seq analysis revealed genomic regions most sensitive to ITK inhibition are enriched for NF-κB and AP-1 motifs. Together, these data indicate a key role for ITK in orchestrating optimal activation of separate TCR downstream pathways, specifically aiding NF-κB activation. More broadly, I describe a mechanism by which variation in TCR signal strength can produce patterns of graded gene expression in activated T cells.

GB virus C (GBV-C) is a lymphotropic human virus which was recently assigned to a new genus Pegivirus within the Flaviviridae family. GBV-C infection is found worldwide, and viremia prevalence is about 1% to 4% in healthy blood donors and up to 42% in HIV-infected individuals. In clinical studies, GBV-C coinfection is associated with prolonged survival of HIV-infected individuals. GBV-C infection modestly alters T cell homeostasis in vivo through various mechanisms, including modulation of chemokine and cytokine release and receptor expression, and by diminution of T cell activation, proliferation and apoptosis, all of which may contribute to improved HIV clinical outcomes. This thesis explores the interrelationship between GBV-C infection and immunoactivation and identifies potential mechanisms by which GBV-C reduces immunoactivation. Chronic HIV infection is associated with persistent immunoactivation which contributes to the immune dysfunction. In particular, T cell activation supports HIV replication and correlates with HIV viral load (VL). Persistent immunoactivation also contributes to the depletion of uninfected bystander cells by mechanisms of activation induced cell death (AICD). Although treatment with combination antiretroviral therapy (cART) reduces HIV VL, T cell activation does not return to levels found in HIVuninfected individuals. Sustained immunoactivation is also associated with lower virological response to cART suggesting therapies to reduce immunoactivation in combination with cART may benefit HIV-infected individuals. Since GBV-C infection is associated with reduced immunoactivation, understanding mechanisms by which GBV-C modulates these signaling pathways may provide insights into novel approaches to treat HIV infection and chronic immunoactivation. The effect of GBV-C infection on T cell activation and IL-2 signaling pathways were studied in a cohort of HIV-positive individuals. GBV-C viremic HIV positive individuals on cART have reduced T cell activation which was significantly associated with higher percentage of immunomodulatory CD3 +CD4-CD8-T cells. Ex vivo GBV-C infection was associated with reduced lymphocyte proliferation in response to IL-2, lower frequency of reactivation of latent HIV and protection against AICD. In vitro expression of GBV-C envelope glycoprotein E2 in CD4+ T cell lines inhibited T cell receptor (TCR) induced IL-2 secretion and inhibited IL-2 signaling pathways. This effect was mediated at least in part by reducing activation of lymphocyte specific tyrosine kinase (Lck). Through deletion mutagenesis, the inhibitory motif within the viral protein was mapped to a region that contains a predicted Lck substrate, a highly conserved tyrosine at position 87 (Y87). Lck phosphorylated GBV-C E2 protein in vitro and mutation of Y87 residue abolished the inhibitory effects of E2 protein. Synthetic peptides containing this inhibitory motif competed for Lck phosphorylation and inhibited TCR signaling in primary human T cells. The number of GBV-C infected T cells was found to be low in vivo, yet GBV-C infection reduced global TCR signaling. GBV-C RNA and E2 protein were detected in extracellular microvesicles purified from GBV-C infected human serum or the culture supernatant of E2 expressing cells, and these microvesicles inhibited TCR signaling in uninfected bystander T cells. Together, these data identify a novel mechanism by which GBV-C infection leads to global reduction in T cell activation and IL-2 signaling in the infected host, and provide a working model in which the viral envelope glycoprotein serves as a substrate for Lck and competes for Lck phosphorylation in the infected T cells and in uninfected bystander T cells.

γδ T cells are unconventional T cells that that can recognize infected and transformed cells via their γẟ TCR, thus promoting different immune responses. In addition, several studies showed that γδ T cells are important in the protection against different pathogens in early life, such as human cytomegalovirus (CMV). The diversity of the γδ TCR repertoire is mainly generated in the complementarity determining region 3 (CDR3) where V(D)J recombination takes place. One of the main players in the junctional diversity is the terminal-deoxynucleotidyl-transferase (TdT) enzyme responsible for the random template-independent nucleotide addition at the junction of the joining gene segments.In the mouse model it is established that during development, especially before birth, innate γδ T cell subsets are generated in waves and their generation depends on the type of hematopoietic stem and precursor cells (HSPC). These γδ T cells express a semi-invariant γδ TCR and can acquire a functional program already in the thymus. In human, in contrast, the idea of γδ T cells as innate-like lymphocytes is questioned by recent works showing that the γδ TCR repertoire of human pediatric thymuses and of term-delivery cord blood is highly diverse. Here, by analyzing in detail human fetal and post-natal thymi, we observed striking differences between fetal and post-natal γδ thymocytes at the γδ TCR repertoire and functional level. In contrast to post-natal γδ thymocytes, fetal γδ thymocytes were functionally programmed, expressed low levels of TdT and were highly enriched for invariant/public CMV-reactive CDR3 sequences (TRGV8-TRJP1-CATWDTTGWFKIF, TRDV2-TRDD3-CACDTGGY, and TRDV1-TRDD3-CALGELGD). The rearrangements of these invariant sequences were driven by short-homology repeats at the end of the involved gene segments, as it was observed in the mouse. In addition, we investigated the role of HSPC in the generation of this invariant γδ thymocytes by using an in vitro T cell development system and we showed that only fetal HSPC could generate γδ T cells enriched for the same specific features that were found in the ex-vivo fetal γδ thymocytes. Moreover, we showed that the RNA-binding protein Lin28b, highly expressed in fetal γδ T cells, reprogrammed the term delivery HSPC towards the generation of γδ T cells resembling to their fetal counterpart.In conclusion, we show that the human fetal thymus generates, in a HSPC- and Lin28b-dependent manner, innate invariant γδ T cells with programmed effector functions that might provide protection to the fetus during congenital infections, such as against CMV. / Doctorat en Sciences biomédicales et pharmaceutiques (Pharmacie) / info:eu-repo/semantics/nonPublished

Helper T cells direct the immunological response to foreign pathogens and cancer. To become activated, helper T cells must recognize unique peptides presented on major histocompatibility complex II (pMHCII) by antigen presenting cells (APCs) with their T cell receptor (TCR). While much is known about helper T cell activation signaling cascades and the subsequent roles of helper T cell subsets, the initiation of helper T cell activation by the TCR and other co-receptors is less well understood. Specifically, the affinity of the TCR for its pMHCII can change helper T cell subset fate, proliferation, and alter the risk for activation induced cell death. High affinity TCRs are attractive targets for immunotherapies, but little is known about how helper T cells respond to high affinity TCRs. Here we describe high affinity TCR activation thresholds for both full length TCRs and chimeric antigen receptor TCRs both with and without the presence of the coreceptor CD4 and propose a mechanism whereby CD4 inhibits T cell activation via Lck sequestration and a CD4-independent method. Dysregulated helper T cells play critical roles in the development and perpetuation of systemic lupus erythematosus (SLE), a systemic autoimmune disease that causes widespread inflammation and organ damage throughout the body. Chronic inflammation in SLE affects the immune response to viruses and the risk of developing cancer. However, in SLE patients, it is unclear if viruses initiate the development of cancer directly or if the effects are non-interacting and concomitant. Here we describe the interactions between SLE, viruses, and cancer risk revealing that viruses and SLE do interact to increase the both the overall cancer risk and the risk for hematological malignancies. Due to vaccine efficacy, vaccine preventable diseases (VPDs) are no longer commonly experienced or understood by the public. Vaccines are a victim of their own success and according to the World Health Organization (WHO), vaccine hesitancy (VH) is one of the top threats to global health. VH is the refusal to accept vaccinations and the reasons for VH vary across time, place, and vaccine. Refuting VH is difficult as directly confronting false assumptions can cause individuals to become more entrenched in their position resulting in confirmation bias. Adults with VH attitudes are often motivated by concerns over personal liberty, harm, independence, and body purity. Here we describe the results of a VPD interview- and education-based intervention geared towards promoting positive vaccine attitudes for young adults and demonstrate that education focused on VPDs is more effective than vaccine safety.

The 23 pairs of chromosomes comprising the human genome are intricately folded within the nucleus of each cell in a manner that promotes efficient gene regulation and cell function. Consequently, active gene rich regions are compartmentally segregated from inactive gene poor regions of the genome. To better understand the mechanisms driving compartmentalization we investigated what would occur if this system was disrupted. By digesting the genome to varying sizes and analyzing the fragmented 3D structure over time, our work revealed essential laws governing nuclear compartmentalization. At a finer resolution within compartments, chromatin forms loop structures capable of regulating gene expression. Genome wide association studies have identified numerous single nucleotide polymorphisms (SNPs) associated with the neuropsychiatric disease schizophrenia. When these SNPs are not located within a gene it is difficult to gain insight into disease pathology; however, in some cases chromatin loops may link these noncoding schizophrenia risk variants to their pathological gene targets. By generating 3D genome maps, we identified and analyzed loops of glial cells, neural progenitor cells, and neurons thereby expanding the set of genes conferring schizophrenia risk. The binding of T-cell receptors (TCRs) to foreign peptides on the surface of diseased cells triggers an immune response against the foreign invader. Utilizing available structural information of the TCR antigen interface, we developed computational methods for successful prediction of TCR-antigen binding. As this binding is a prerequisite for immune response, such improvements in binding prediction could lead to important advancements in the fields of autoimmunity and TCR design for cancer therapeutics.